Results 181 to 190 of about 8,610,280 (359)
Biological Psychiatry: Global Open Science—Supporting Open Science and Global Diversity in Research
Deanna M. Barch
doaj +1 more source
Open science, done wrong, will compound inequities
Tony Ross-Hellauer
semanticscholar +1 more source
Angiotensin II (AngII), a neuropeptide, interacts with amyloid‐β (Aβ), a key player in Alzheimer's disease. This study reveals that AngII reduces Aβ aggregation and membrane disruption in vitro. Biophysical assays and molecular modeling suggest AngII binds disordered Aβ forms, potentially modulating early amyloidogenic events and contributing to ...
Mohsen Habibnia+5 more
wiley +1 more source
Open Access Federation for Library and Information Science [PDF]
Anita Sundaram Coleman, Joseph Roback
openalex +1 more source
Atovaquone is an antimalarial requiring potentiation for sufficient efficacy. We pursued strategies to enhance its activity, showing that 4‐nitrobenzoate inhibits 4‐hydroxybenzoate polyprenyltransferase, decreasing ubiquinone biosynthesis. Since atovaquone competes with ubiquinol in mitochondria, 4‐nitrobenzoate facilitates its action, potentiating ...
Ignasi Bofill Verdaguer+7 more
wiley +1 more source
Österreichischer Bibliothekartag 2019, Graz, Austria, 10 Sep 2019 - 13 Sep 2019; doi:10.5281/ZENODO ...
openaire +3 more sources
Cells must clear mislocalized or faulty proteins from membranes to survive. The AAA+ ATPase Msp1 performs this task, but dissecting how its six subunits work together is challenging. We engineered linked dimers with varied numbers of functional subunits to reveal how Msp1 subunits cooperate and use energy to extract proteins from the lipid bilayer ...
Deepika Gaur+5 more
wiley +1 more source
Advancements in Nanotechnology Open Opportunities for Environmental Sciences [PDF]
Clifford Frith
openalex +1 more source
Organoids in pediatric cancer research
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source